Exendin (9-39) Acetate 10 mg/vial (Clinalfa basic)


A considerable number of publications on Clinalfa products used in clinical trials are available. The most important publications are listed below. For a comprehensive list please contact us.


All information is compiled to the best of our knowledge. We cannot be made liable for any possible errors or misprints.


Literature references citing the Clinalfa basic product


Melhorn, S. J., Tyagi, V., Smeraglio, A., Roth, C. L. and Schur, E. A.
Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.
Appetite 82, 85-90 (2014)

Steinert, R. E., Schirra, J., Meyer-Gerspach, A. C., Kienle, P., Fischer, H., Schulte, F., Goeke, B. and Beglinger, C.
Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
Am. J. Clin. Nutr. 100, 514-523 (2014)

van Bloemendaal, L., RG, I. J., Ten Kulve, J. S., Barkhof, F., Konrad, R. J., Drent, M. L., Veltman, D. J. and Diamant, M.
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Diabetes 63, 4186-4196 (2014)



Woerle, H. J., Carneiro, L., Derani, A., Goke, B. and Schirra, J.
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.
Diabetes 61, 2349-2358 (2012)



Salehi, M., Aulinger, B., Prigeon, R. L. and D'Alessio, D. A.
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.
Diabetes 59, 1330-1337 (2010)

Witte, A. B., Gryback, P., Jacobsson, H., Naslund, E., Hellstrom, P. M., Holst, J. J., Hilsted, L. and Schmidt, P. T.
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Scand. J. Gastroenterol. 46, 428-435 (2010)



Schirra, J., Nicolaus, M., Woerle, H. J., Struckmeier, C., Katschinski, M. and Goke, B.
GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
Neurogastroenterol. Motil. 21, 609-618, e21-22 (2009)



Salehi, M., Vahl, T. P. and D'Alessio, D. A.
Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
J. Clin. Endocrinol. Metab. 93, 4909-4916 (2008)



Schirra, J., Nicolaus, M., Roggel, R., Katschinski, M., Storr, M., Woerle, H. J. and Goke, B.
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Gut 55, 243-251 (2006)


Literature references citing the active pharmaceutical ingredient (API)


Nicolaus, M., Brodl, J., Linke, R., Woerle, H. J., Goke, B. and Schirra, J.
Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
J. Clin. Endocrinol. Metab. 96, 229-236 (2011)